期刊文献+

石家庄地区人群中PPARγ_2基因突变与瘦素分泌和肥胖症关系的初步研究 被引量:2

The relationship among peroxisome proliferator-activated receptor γ_2( PPARγ_2) gene mutation and leptin secretion and adiposity in Shijiazhuang area.
下载PDF
导出
摘要 目的 旨在研究过氧化物酶增殖物活化受体γ2 (PPARγ2 )基因Pro12Ala多态性与Leptin分泌和肥胖症的关系。方法 选择石家庄地区汉族2 0 8例,非肥胖和肥胖个体人,应用聚合酶链式反应-限制性片断长度多态性分析(PCR-RFLP) ,检测PPARγ2 基因突变。酶联免疫法(ELISA)测定血清瘦素(Leptin)浓度。结果 研究对象中非肥胖与肥胖个体血清瘦素浓度有显著性差别,非肥胖与肥胖组中均存在PPARγ2 基因Plo12和Ala12变异,但肥胖组中PPARγ2 基因Plo12和Ala12变异频率明显增高。结论 肥胖个体中PPARγ2 基因有Ala12突变是导致血清瘦素分泌增高、肥胖症发生有密切关系的遗传因素之一。 Objective:To study the relationship among PPARγ 2 gene Pro12Ala polymorphism and leptin secretion and adiposity. Methods:208 cases were chose in Shijiazhuang area including adiposity group and control group. PPARγ 2 gene mutation was examined using PCR- RFLP, and serum leptin concentration was examined using ELISA.Results:The serum leptin concentrations of the adiposity group were significantly different from that of the control group. The two groups both had the PPARγ 2 gene mutation (Pro12Ala), but the frequency of the gene variation of the adiposity group was higher than that of the control group. Conclusion:The Ala12 variation in PPARγ 2 gene of adiposity is one of the inherited factors, which speed the serum leptin's secretion and have germane relationships with adiposity.
出处 《中国优生与遗传杂志》 2005年第5期25-26,16,共3页 Chinese Journal of Birth Health & Heredity
  • 相关文献

参考文献12

  • 1顾卫琼,陈名道,唐金凤,李凤英,陈春荣,罗敏,陈家伦,许曼音.中国人血清瘦素水平与肥胖度的关系[J].中华内分泌代谢杂志,1999,15(1):15-18. 被引量:193
  • 2陈名道,顾卫琼,唐金凤,李凤英,陈春荣,胡仁明,许曼音,陈家伦.口服糖耐量试验中血糖和胰岛素动态变化对瘦素的影响[J].中华内科杂志,1999,38(11):740-743. 被引量:20
  • 3罗敏,左祥生.核转录因子PPARγ与肥胖、糖尿病的临床联系及进展[J].辽宁实用糖尿病杂志,2001,9(2):49-51. 被引量:3
  • 4Yen CJ, Beamer BA,Negri C, et al.Molecular scanning of the human peroxisome proliferator activated receptor gmma(hPPARγ)gene in diabetic caucasians:identifcation of a Prol12AlaPPARγ2 missense mutation[J].Biochem Biophys Res Commun, 1997,241:270.
  • 5Considine RV,consience EL,Williams CJ,et al.Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity[J]. J Clin Invest,1995,95:2986-2988.
  • 6Saladin R,Fajas L,Dana S,et al.Differential regulation of peroxisome proliferator activated receptor RNA expression in the early stages of adipogenesis[J].Cell Geowth Differe,1999,10:43-48.
  • 7Cole SA,Mitchell BD,Hsueh WC, et al.The Prol2Ala variant of peroxisome proliferator-gamma2(PPAR-GAMMA2)is associated with measure of obesity in Mexican Americans[J].Int J Obes Relat Metab Disord, 2000,4:522.
  • 8LI WD,Lee JH,Price RA.The peroxisome proliferator activated receptor gamma2Prol2Ala mutation is associated with early onset extreme obesity and reduced fasting glucose[J].Mol Genet Metab,2000,2:159.
  • 9Ma Z,Giingerich RL,Santiago JV, et al.Radioim munoassay of leptin in human plasma[J].Clin Chem,1996,42:942-946.
  • 10Considine RV, Sinha MK,Heiman ML,et al.Serumimmunore active leptin concentrations in normal-weight and obese humans[J].Nengl J Med,1996,334:292-295.

二级参考文献20

  • 1贾伟平,项坤三,丁炜,陆俊茜.男性中国人体脂分布与激素模式[J].中华内分泌代谢杂志,1998,14(2):78-81. 被引量:20
  • 2胰岛素B细胞功能协作组.正常人馒头餐试验过程中血糖、胰岛素、C肽的研究[J].中华医学杂志,1982,62:643-647.
  • 3[1]Elbrecht A, Chen Y, Cullinan CA, et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptor γland γ2. Biochem Biophys Res Commun 1996;224:431.
  • 4[2]Saladin R, Fajas L, Dana S, et al. Differential regulation of peroxisome proliferator activated receptor gamma 1 (PPAR gamma 1)and PPAR gamma 2 messenger RNA expression in the early stages of adipogenesis. Cell Growth Differe 1990; 10: 43 ~ 48.
  • 5[3]Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999:4:585~595.
  • 6[5]Cole SA, Mitchell BD, Hsueh WC, et al. The Pro12Ala variant of peroxisome proliferator - activated receptor - gamma2(PPAR- gamma2)is associated with measure of obesity in Mexican Americans. Iht J Obes Relat Metab Disord 2000;4:522.
  • 7[6]Li WD, Lee JH, Price RA. The peroxisome proliferator activated receptor gamma 2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose. Mol Genet Metab 2000;2:159.
  • 8[7]Miles PD, Barak Y, He W, et al. Improved insulin - sensitivity in mice heterozygous for PPAR - gamma deficiency. J Clin Invest 2000;3:287.
  • 9[8]Komers R, Vrana A. Thiazolidinediones - tools for the research of metabolic syndrome X. Physiol Res 1998; 4:215 ~225.
  • 10陈名道,中华内科杂志,1999年,38卷,61页

共引文献207

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部